journal article·2026-08Open access

Mild photothermal therapy ameliorates neurogenic bladder after sacral spinal cord injury via multi-target effects

Kaiping Bai, Susu Guo, Junxiang Wen, Jiajie Zhang, Xiaoling Huang, Fei Yuan, Yanping Hou, Pengtao Liu, Zeyu Xiao, Kai Cui, Jie Sun

Abstract

Neurogenic bladder (NB) is a devastating complication following sacral spinal cord injury (SSCI), often leading to urinary incontinence, recurrent infections, and progressive renal dysfunction, which severely impair patients' quality of life and survival. Current therapeutic options remain largely palliative and fail to reverse the underlying neurogenic pathology. This study employed mild photothermal therapy (MPTT) to treat SSCI-induced NB in rats and systematically investigated its efficacy and mechanisms. Results showed that MPTT effectively improved bladder morphology and urodynamic parameters, with more significant effects observed in early intervention. Mechanistically, MPTT inhibited bladder fibrosis, alleviated chronic inflammation, restored the balance between cell proliferation and apoptosis, promoted functional angiogenesis, and repaired structural damage and function of bladder nerve fibers. MPTT ameliorates SSCI-NB function through multi-target effects, and its time-dependent therapeutic efficacy suggests the necessity of early and repeated interventions, providing experimental and theoretical evidence for new NB treatment strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Urinary Bladder and Prostate Research · Laser Applications in Dentistry and Medicine · Spinal Cord Injury Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (84)

Show source-provided references
1. Neurogenic bladder: epidemiology, diagnosis, and management10.1055/s-0040-1713876 ↗
2. Pediatric neurogenic bladder and bowel dysfunction:will my child ever be out of diapers?10.1016/j.euf.2020.01.003 ↗
3. Lower urinary tract dysfunction in the neurological patient:clinical assessment and management10.1016/S1474-4422(15)00070-8 ↗
4. Translating promisingstrategies for bowel and bladder management in spinal cord injury10.1016/j.expneurol.2018.05.006 ↗
5. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury10.1007/s00345-018-2301-z ↗
6. Urinary tract infection diagnostic and management considerations in people with spinal cord injury and neurogenic bladder10.1016/j.idc.2024.03.012 ↗
7. Longitudinal trajectories of clean intermittent catheterization responsibility in youths with Spina Bifida10.1097/JU.0000000000002204 ↗
8. Nanoparticles for photothermal therapies10.1039/C4NR00708E ↗
9. Enhancing the efficiency of mild-temperature photothermal therapy for cancer assisting with various strategies10.3390/pharmaceutics14112279 ↗
10. Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis10.1038/s41392-022-01199-1 ↗
11. Magnetic systems for cancer immunotherapy10.1016/j.apsb.2021.03.023 ↗
12. Mild photothermal therapy assist in promoting bone repair: related mechanism and materials
13. Strength in numbers: a giant NIR-II AIEgen with one-for-all phototheranostic features for exceptional orthotopic bladder cancer treatment10.1002/anie.202417865 ↗
14. Gold nanorods assisted photothermal therapy of bladder cancer in mice: a computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer10.1016/j.cmpb.2023.107363 ↗
15. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
16. Self-stacked small molecules for ultrasensitive, substrate-free Raman imaging in vivo10.1038/s41587-024-02342-9 ↗
17. Oral delivery of aptamer-decorated SICTERS Raman probes for colonoscopy-guided resection and photothermal immunization of microtumors10.1126/sciadv.adx5246 ↗
18. Low-temperature photothermal therapy: strategies and applications10.34133/2021/9816594 ↗
19. anomaterial-based therapeutics for antibiotic-resistant bacterial infections10.1038/s41579-020-0420-1 ↗
20. New insights into nanotherapeutics for periodontitis: a triple concerto of antimicrobial activity, immunomodulation and periodontium regeneration10.1186/s12951-023-02261-y ↗
21. Effect of engineered cyanobacterial capsules on a neurogenic bladder after Spinal cord injury10.1021/acsnano.4c14140 ↗
22. Effect of photobiomodulation on lower urinary tract dysfunction in rat cystitis model10.1371/journal.pone.0306527 ↗
23. Mild thermal stimulation of the buttock skin increases urinary voiding efficiency in anesthetized rats10.1016/j.autneu.2022.103022 ↗
24. Emerging roles of the TRPV4 channel in bladder physiology and dysfunction10.1113/JP279776 ↗
25. Is there enough evidence to justify the use of laser and other thermal therapies in female lower urinary tract dysfunction? Report from the ICI-RS 2019
26. PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay10.1016/j.ccell.2024.02.002 ↗
27. Remodeling of extracellular matrix in the urinary bladder of paraplegic rats results in increased compliance and delayed fiber recruitment 16 weeks after spinal cord injury10.1016/j.actbio.2022.01.015 ↗
28. Defective extracellular matrix remodeling in brown adipose tissue is associated with fibro-inflammation and reduced diet-induced thermogenesis10.1016/j.celrep.2023.112640 ↗
29. Biomarkers of spinal cord injury and ensuing bladder dysfunction10.1016/j.addr.2014.11.007 ↗
30. Antifibrotic effects of tetrahedral framework nucleic acids by inhibiting macrophage polarization and macrophage-myofibroblast transition in bladder remodeling10.1002/adhm.202203076 ↗
31. Mechanosensitive Piezo1 channels promote neurogenic bladder fibrosis via regulating TGF-β1/smad and Hippo/YAP1 pathways10.1016/j.yexcr.2024.114218 ↗
32. Peptide-functionalized prussian blue nanomaterial for antioxidant stress and NIR photothermal therapy against Alzheimer's Disease10.1002/smll.202206959 ↗
33. Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy10.1016/j.redox.2020.101600 ↗
34. Fibronectin-1: a predictive immunotherapy response biomarker for muscle-invasive bladder cancer10.56434/j.arch.esp.urol.20237601.7 ↗
35. Application of surface plasmon resonance imaging biosensors for determination of fibronectin, laminin-5 and type IV collagen in serum of transitional bladder cancer patients10.1016/j.jpba.2022.115103 ↗
36. Multimodal single-cell analyses outline the immune microenvironment and therapeutic effectors of interstitial Cystitis/Bladder pain syndrome
37. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy10.1021/acsnano.8b00309 ↗
38. Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns10.1089/107999000750053708 ↗
39. A novel "hot spring"-mimetic hydrogel with excellent angiogenic properties for chronic wound healing10.1016/j.biomaterials.2020.120414 ↗
40. Aggregation-induced emission nanoparticles for single near-infrared light-triggered photodynamic and photothermal antibacterial therapy10.1021/acsnano.2c00734 ↗
41. Regulation of macrophage polarization through periodic photo-thermal treatment to facilitate osteogenesis10.1002/smll.202202691 ↗
42. Extracellular vesicle proteomics identify neutrophils as potential mediators of bladder radiotoxicity in prostate cancer10.1016/j.canlet.2025.217931 ↗
43. Urinary bladder sigma-1 receptors: a new target for cystitis treatment10.1016/j.phrs.2020.104724 ↗
44. Inflammation-targeting mesenchymal stem cells combined with photothermal treatment attenuate severe joint inflammation
45. An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer10.1038/s41467-021-25103-7 ↗
46. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors10.1186/s40364-021-00299-4 ↗
47. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury10.1172/JCI136908 ↗
48. Sishen pills inhibit inflammatory dendritic cell differentiation via miR-505-3p mediated E-cadherin downregulation in ulcerative colitis10.1016/j.phymed.2024.156035 ↗
49. Mechanical stimulation of anti-inflammatory and antioxidant hydrogels for rapid Re-Epithelialization10.1002/adma.202312740 ↗
50. S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome10.1186/s40364-025-00763-5 ↗
51. Nerve growth factor-targeting nanocluster-antibody-drug conjugates for intravesical precision theranostics of interstitial cystitis10.1016/j.biomaterials.2025.123840 ↗
52. RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis10.1152/ajprenal.00472.2006 ↗
53. Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats10.1186/1423-0127-21-43 ↗
54. Comparative study of bladder augmentation using different biomimetic scaffolds: Electrospun nanofiber vs. extracellular matrix scaffold with adipose-derived stem cells10.1097/JS9.0000000000003152 ↗
55. Integrated proteogenomic characterization of urothelial carcinoma of the bladder10.1186/s13045-022-01291-7 ↗
56. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma10.1038/s41467-020-18916-5 ↗
57. Efficacy of peripheral electrical nerve stimulation on improvements of urodynamics and voiding diary in patients with neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis10.1097/JS9.0000000000000168 ↗
58. Molecular mechanisms of neurogenic lower urinary tract dysfunction after Spinal cord injury10.3390/ijms24097885 ↗
59. Mechano-activated cell therapy for accelerated diabetic wound healing10.1002/adma.202304638 ↗
60. Curcumin-zinc framework encapsulated microneedle patch for promoting hair growth10.7150/thno.84118 ↗
61. ABT-263 exerts a protective effect on upper urinary tract damage by alleviating neurogenic bladder fibrosis10.1080/0886022X.2023.2194440 ↗
62. Cellular stress and molecular responses in bladder ischemia10.3390/ijms222111862 ↗
63. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis10.1136/annrheumdis-2016-210229 ↗
64. Porous gelatin microspheres implanted with adipose mesenchymal stromal cells promote angiogenesis via protein kinase B/endothelial nitric oxide synthase signaling pathway in bladder reconstruction10.1016/j.jcyt.2023.08.005 ↗
65. Integrated 'Shield-Spear' biological patch for fibrosis-free bladder reconstruction
66. Intrauterine neuromuscular and stromal dysplasia of the bladder in retinoic acid-induced myelomeningocele fetal rats10.1016/j.tice.2022.101872 ↗
67. Curcumin/pEGCG-encapsulated nanoparticles enhance spinal cord injury recovery by regulating CD74 to alleviate oxidative stress and inflammation10.1186/s12951-024-02916-4 ↗
68. Enhanced tumor-targeted delivery of arginine-rich peptides via a positive feedback loop orchestrated by Piezo1/integrin β1 signaling axis
69. A tissue bandage for pelvic ganglia injury10.1038/s41467-024-53302-5 ↗
70. Microenvironment responsive nanocomposite hydrogel with NIR photothermal therapy, vascularization and anti-inflammation for diabetic infected wound healing
71. Smart-responsive multifunctional therapeutic system for improved regenerative microenvironment and accelerated bone regeneration via mild photothermal therapy
72. A multi-responsive hydrogel combined with mild heat stimulation promotes diabetic wound healing by regulating inflammatory and enhancing angiogenesis
73. Spinal cord injury causes marked tissue rearrangement in the urethra-experimental study in the rat10.3390/ijms232415951 ↗
74. Slow development of bladder malfunction parallels spinal cord fiber sprouting and interneurons' loss after spinal cord transection10.1016/j.expneurol.2021.113937 ↗
75. Efficiency and safety of noninvasive and intravesical therapy for adult neurogenic lower urinary tract dysfunction: a systematic review and network meta-analysis of randomized controlled trials10.1007/s40265-025-02171-3 ↗
76. Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature10.1016/j.eururo.2017.11.002 ↗
77. Morphology of nervous lesion in the spinal cord and bladder of fetal rats with myelomeningocele at different gestational age10.1016/j.jpedsurg.2013.08.021 ↗
78. Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis10.1016/j.biopha.2022.113915 ↗
79. Binding mechanism and antagonism of the vesicular acetylcholine transporter VAChT10.1038/s41594-024-01462-9 ↗
80. Antinociceptive effect of the calcitonin gene-related peptide receptor antagonist BIBN4096BS in mice with bacterial cystitis10.1152/ajprenal.00217.2023 ↗
81. Amniotic fluid stem cells improve rat bladder dysfunction after pelvic nerve transection10.1177/0963689720909387 ↗
82. A new rat model of sacral cord injury producing a neurogenic bladder and its functional and mechanistic studies10.3390/biom14091141 ↗
83. Anesthetic protocols for urodynamic studies of the lower urinary tract in small rodents-A systematic review10.1371/journal.pone.0253192 ↗
84. Effect of anesthetics on reflex micturition in the chronic cannula-implanted rat10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O ↗